Latest News - Baxter
Top Corporates Hub
Baxter
Baxter International: The Gains Can Continue, But Should Slow
03.08.2026 03:06
Baxter International has shown early signs of a turnaround, with improving execution and raised revenue guidance supporting cautious optimism. Learn more about BAX stock here.
Baxter (BAX) Stock Gets Fair Value Boost After Q2 Beat And Higher Targets
02.08.2026 01:10
Baxter International is back in focus after the fair value estimate in one widely used model moved from US$21.54 to US$27.29, a change of about 27% that feeds directly into updated price target discussions. Analysts are linking this shift to fresh views on earnings execution, segment performance and medium term growth visibility after the latest Q2 results and guidance. As you read on, you will see how to track these changing views and what to watch as the Baxter International story develops...
Baxter International Q2 Earnings Call Highlights
01.08.2026 04:02
Baxter International (NYSE:BAX) reported second-quarter 2026 results that exceeded its expectations, supported by broad-based sales growth, strong demand in Advanced Surgery and drug compounding, and a $75 million tariff refund. The company raised its full-year organic sales-growth outlook and incre
Why Baxter International Stock Skyrocketed by 19% This Week
01.08.2026 00:23
The company's second-quarter performance was impressive.
Do Wall Street Analysts Like Baxter International Stock?
31.07.2026 11:23
Baxter International has significantly underperformed the broader market over the past year, although analysts remain neutral amid improving fundamentals and recovery prospects.
Baxter International (NYSE:BAX) Jumps After Q2 Earnings Beat and Raised Outlook
30.07.2026 12:24
Baxter International (BAX) crushed Q2 estimates, boosting revenue to $2.96B and EPS to $0.56, while raising full-year guidance, sending shares up 14%.
Baxter Reports Second-Quarter 2026 Results
30.07.2026 11:15
DEERFIELD, Ill., July 30, 2026--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2026.
Baxter Earnings: What To Look For From BAX
29.07.2026 16:05
Healthcare company Baxter International (NYSE:BAX) will be reporting results this Thursday before market open. Here’s what you need to know.
Watch These 4 Medical Product Stocks for Q2 Earnings: Beat or Miss?
29.07.2026 14:54
Medical product makers face Q2 margin pressure from tariffs and inflation even as demand stays strong. See which earnings reports could surprise.
Baxter (BAX) Stock May Be 19% Undervalued On Cash Flow
29.07.2026 12:09
Baxter International stock has delivered a steep decline of about 64.6% over the past five years, yet current valuation checks suggest the shares may now be trading below an estimate of intrinsic value. With both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples screening the stock as undervalued, investors are weighing whether this signals an opportunity or a value trap. Baxter International is down roughly 64.6% over five years, which puts recent share price...
Why Baxter (BAX) Stock Is Up Today
28.07.2026 04:13
Shares of healthcare company Baxter International (NYSE:BAX) jumped 3.6% in the afternoon session after TD Cowen raised its price target on the stock to $24 from $20. The firm maintained its hold rating on the shares, which suggests the analyst recommends neither buying nor selling the stock at its current price. However, the increased price target indicates a more positive valuation outlook for the company than before. The move from the investment firm comes as Baxter holds an average rating of
What's going on in today's session: S&P500 gap up and gap down stocks
14.07.2026 14:35
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Tuesday. Stay informed about the latest market trends.
Trading Halt: Halt status updated at 10:10:00 AM ET: Quotation Resumption: IPO Security - Released for Quotation
14.07.2026 13:07
Baxter International's Q2 2026 Earnings: What to Expect
08.07.2026 11:14
Baxter International will release its second-quarter earnings soon, and analysts anticipate a double-digit profit dip.
These S&P500 stocks are moving in today's pre-market session
07.07.2026 12:35
Pre-market stock analysis of S&P500 stocks on 2026-07-07: top gainers and losers in today's session.
3 Value Stocks We Keep Off Our Radar
07.07.2026 10:25
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason — five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
These S&P500 stocks are moving in today's session
02.07.2026 16:35
Curious about the top performers within the S&P500 index in the middle of the day on Thursday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
MediThinQ and Synovis Micro Companies Alliance, Inc. Announce Strategic Global Distribution Agreement to Redefine Microsurgery with the SHIYA 3D Visualization Platform
18.06.2026 14:01
MediThinQ, a South Korea-based innovator in surgical visualization technologies, has entered into an exclusive multi-year distribution agreement with Synovis Micro Companies Alliance, Inc. ("Synovis MCA"), a subsidiary of Baxter International Inc. (NYSE:BAX) and trusted leader in microsurgical devices and solutions, to commercialize SHIYA, its 3D surgical visualization platform. Terms of this agreement were not disclosed.
Reasons to Retain Baxter International Stock in Your Portfolio for Now
16.06.2026 18:14
BAX is pursuing a broad turnaround as innovation, resilient demand, and AI integration support recovery despite regulatory risks and margin pressure.
Baxter (BAX) Stock After Recent Rebound Is The Discount To DCF Value Warranted
15.06.2026 01:11
Wondering whether Baxter International at US$20.86 is a bargain or a value trap? This article breaks down what the current share price might be telling you about the stock. The stock has risen 7.6% over the past week and 20.6% over the past month, yet is still down 7.0% year to date and has declined 31.3% over the last year. This raises questions about how the market now views its risk and potential. Recent coverage has focused on Baxter International's position within the medical equipment...